Titre : | Two cases of "cannabis acute psychosis" following the administration of oral cannabis |
Titre traduit : | (deux cas de psychose aigüe dûe au cannabis suite à une ingestion de cannabis par voie orale) |
Auteurs : | B. FAVRAT ; A. MENETREY ; M. AUGSBURGER ; L. E. ROTHUIZEN ; M. APPENZELLER ; T. BUCLIN ; M. PIN ; P. MANGIN ; C. GIROUD |
Type de document : | Périodique |
Année de publication : | 2005 |
Format : | 6 p. / graph. |
Note générale : |
BMC Psychiatry, 2005, 5, (17) |
Langues: | Français |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Thésaurus mots-clés VOIE D'ADMINISTRATION ; ETUDE DE CAS ; TROUBLE BIPOLAIRE ; CANNABIS ; PSYCHOSE ; VOIE ORALE ; PARANOIA ; TETRAHYDROCANNABINOLThésaurus géographique SUISSE |
Résumé : |
ENGLISH : Background: Cannabis is the most commonly used illegal drug and its therapeutic aspects have a growing interest. Short-term psychotic reactions have been described but not clearly with synthetic oral THC, especially in occasional users. Case presentations: We report two cases of healthy subjects who were occasional but regular cannabis users without psychiatric history who developed transient psychotic symptoms (depersonalization, paranoid feelings and derealisation) following oral administration of cannabis. In contrast to most other case reports where circumstances and blood concentrations are unknown, the two cases reported here happened under experimental conditions with all subjects negative for cannabis, opiates, amphetamines, cocaine, benzodiazepines and alcohol, and therefore the ingested dose, the time-events of effects on behavior and performance as well as the cannabinoid blood levels were documented. Conclusion: While the oral route of administration achieves only limited blood concentrations, significant psychotic reactions may occur. (Author' s abstract) |
Note de contenu : | graph. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 26 |
Affiliation : |
Unité de Médecine du Trafic, Institut Universitaire de Médecine Légale (IUML), 1005 Lausanne. Email : bernard.favrat@hospvd.ch Suisse. Switzerland. |
Numéro Toxibase : | 1301250 |
Centre Emetteur : | 13 OFDT |
Cote : | A02208 |
Lien : | http://www.biomedcentral.com/1471-244X/5/17/ |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil